| 11851708 |
Diagnosis and treatment of psoriatic arthritis |
Shang-Hung Lin, Chang-Chun Hsiao |
2023-12-26 |
|
| 11220712 |
Diagnosis and treatment of psoriatic arthritis |
Shang-Hung Lin, Chang-Chun Hsiao |
2022-01-11 |
|
| 10717168 |
Glass treatment apparatus and methods of treating glass |
James William Brown, Yu-Chang Hong, Naiyue Zhou |
2020-07-21 |
$52,287,000 |
| 9983218 |
Indole and indoline derivatives and methods of use thereof |
Michael R. Schrimpf, Tao Li, Gregory A. Gfesser, Kathleen H. Mortell, Ramin Faghih +8 more |
2018-05-29 |
$508,120,000 |
| 9625475 |
Indole and indoline derivatives and methods of use thereof |
Michael R. Schrimpf, Tao Li, Gregory A. Gfesser, Kathleen H. Mortell, Ramin Faghih +8 more |
2017-04-18 |
$146,490,000 |
| 9186407 |
Pharmaceutical compositions and their methods of use |
Murali Gopalakrishnan, Marie P. Honore, John Malysz, Jianguo Ji, Tao Li +3 more |
2015-11-17 |
$130,008,000 |
| 9063126 |
Indole and indoline derivatives and methods of use thereof |
Michael R. Schrimpf, Tao Li, Gregory A. Gfesser, Kathleen H. Mortell, Ramin Faghih +8 more |
2015-06-23 |
$83,346,000 |
| 9040568 |
Pharmaceutical compositions for the treatment of pain |
Murali Gopalakrishnan, Jianguo Ji, Tao Li, Kevin B. Sippy |
2015-05-26 |
$584,581,000 |
| 8987453 |
Azaadamantane derivatives and methods of use |
Michael R. Schrimpf, Diana L. Nersesian, Kevin B. Sippy, Jianguo Ji, Tao Li +7 more |
2015-03-24 |
$81,795,000 |
| 8940762 |
Methods for treating pain |
Michael R. Schrimpf, Timothy A. Esbenshade, Chang Z. Zhu |
2015-01-27 |
$84,369,000 |
| 8853241 |
Biaryl substituted azabicyclic alkane derivatives |
Jianguo Ji, Tao Li, Kevin B. Sippy, Murali Gopalakrishnan |
2014-10-07 |
$69,043,000 |
| 8815930 |
Compounds that inhibit TRPV1 and uses thereof |
Richard J. Perner, Brian S. Brown, John Darbyshire |
2014-08-26 |
$130,577,000 |
| 8802711 |
TRPV1 antagonists |
Arthur Gomtsyan, Jerome F. Daanen, Gregory A. Gfesser, Michael E. Kort, Heath A. McDonald +3 more |
2014-08-12 |
$78,239,000 |
| 8778959 |
AZA-bridged ring-fused indoles and indolines |
Lei Shi, William H. Bunnelle, Tao Li, Marc J. Scanio, Michael R. Schrimpf |
2014-07-15 |
$189,930,000 |
| 8598220 |
Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof |
Brian S. Brown, John R. Koenig, Arthur Gomtsyan |
2013-12-03 |
$87,921,000 |
| 8536221 |
Amide derivatives as positive allosteric modulators and methods of use thereof |
Kathleen H. Mortell, Diana L. Nersesian, Michael R. Schrimpf, Murali Gopalakrishnan |
2013-09-17 |
$138,486,000 |
| 8524703 |
Bridgehead amine ring-fused indoles and indolines |
Lei Shi, William H. Bunnelle, Tao Li, Marc J. Scanio, Michael R. Schrimpf |
2013-09-03 |
$128,422,000 |
| 8501769 |
Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof |
Sean Turner, Tammie K. Jinkerson, Arthur Gomtsyan |
2013-08-06 |
$106,821,000 |
| 8487116 |
Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
Arthur Gomtsyan, Erol K. Bayburt, John R. Koenig, Robert G. Schmidt, Kirill A. Lukin +4 more |
2013-07-16 |
$103,995,000 |
| 8486979 |
1,2,4 oxadiazole compounds and methods of use thereof |
Jianguo Ji, Kevin B. Sippy, Tao Li, Murali Gopalakrishnan |
2013-07-16 |
$103,995,000 |
| 8440691 |
Tetrahydroquinolinyl compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof |
Arthur Gomtsyan, Erol K. Bayburt, Robert G. Schmidt, Brian S. Brown, Tammie K. Jinkerson +3 more |
2013-05-14 |
$464,317,000 |
| 8383658 |
Isoxazole based neuronal nicotinic receptor ligands and methods of use |
Murali Gopalakrishnan, Jianguo Ji, Tao Li, Kevin B. Sippy |
2013-02-26 |
$9,076,000 |
| 8350083 |
Antagonists of the TRPV1 receptor and uses thereof |
Arthur Gomtsyan, Robert G. Schmidt, Jerome F. Daanen, Erol K. Bayburt, Steven P. Latshaw |
2013-01-08 |
|
| 8314119 |
Azaadamantane derivatives and methods of use |
Michael R. Schrimpf, Diana L. Nersesian, Kevin B. Sippy, Jianguo Ji, Tao Li +7 more |
2012-11-20 |
|
| 8268853 |
3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof |
Michael R. Schrimpf, Diana L. Nersesian, Ramin Faghih, Gregory A. Gfesser |
2012-09-18 |
$24,393,000 |
